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Abstract 
Alveolar echinococcosis, a serious and often fatal 
human disease, can be efficiently cured only by 
complete surgical resection of the Echinococcus multi- 
locularis lesion. The present study showed that the 
determination in patients who had undergone surgery 
of antibody activity directed against he antigen Em2 
reliably reflected complete or incomplete surgical 
resection. From 9 patients with pre-operative positive 
results in the Em2 enzyme-linked immunosorbent 
assay (Em2-ELISA) and successful surgical resection, 
6 converted to negative within one year and the 
remaining 3 patients within 4 years after surgery. Six 
of 7 additional patients who showed recurrences in an 
average of 6 years after surgery despite assumed 
complete surgical resection, were positive by Em2- 
ELISA at the time of recurrence. Discrimination was 
not possible between these 2 groups of patients when 
using an ELISA employing crude antigen obtained 
from E. granulosus hydatid cyst fluid. 
Introduction 
Alveolar echinococcosis, caused by the larval stage 
of Echinococcus multilocularis, is one of the most lethal 
hehninth infections of humans. Only surgical com- 
plete removal of the entire parasite lesion offers a 
prospect for curative treatment. It has been reported 
that only 26% of cases were resectable in Alaska 
(SCHANTZ et al., 1983). The development of new 
immunodiagnostic techniques for early detection of 
the infection (GOTTSTEIN et al., 1987) and improved 
methods for clinical diagnosis and surgical treatment 
(SCHR~DER & ROBOTTI. 1986: GILLET et al.. 1988) 
resulted in an increased.rate of radical resectabilitv: 
which is presently estimated to be about 40% regard: 
ing central European patients. The ‘radicality’ of the 
resection is very difficult to determine by the 
surgeons, as microlesions and root-like parasite 
protrusions (ECKERT et al.? 1983; MEHLHORN et al., 
1983) mav remain unseen m annarentlv healthv liver 
tissue. Iii this way, some of- these -patients may 
subsequently develop recurrences. Serological tests 
have been used, among others, for post-operative 
follow-up studies. In most studies, crude antigens 
derived from E. granulosus served to detect parasite- 
specific immunoglobulins (reviewed by SCHANTZ et 
al., 1983) or immunoglobulin classes (G~TTSTEIN et 
al., 1984; VUITTON-DROUHARD, 1985). Generally, a 
decrease of antibody concentration was observed after 
surgery. This decrease was more marked in parasite- 
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specific immunoglobulin (Ig) E and IgA levels, 
compared to the parasite-specific IgG. Most of the 
patients investigated were under permanent meben- 
dazole or albendazole treatment, which may have 
influenced the course of serology. Nevertheless, 
antibodies were still detectable for long periods after 
surgical intervention. Based on the interpretation of 
the test results, clear statements regarding the actual 
status of the disease in individual patients were not 
possible in many cases. A recent study performed on 3 
patients with alveolar echinococcosis indicated that 
antibodies detected by the use of a purified E. 
multilocularis antigen -(Em2 antigen) @OTTSTEIN, 
1985) in an enzvme-linked imunosorbent assav (Em2- 
ELISA) declined dramatically within months‘ after 
radical operation (LANIER et al., 1987). In order to 
evaluate this method further as a follow-up technique, 
a study was carried out with 18 selected Swiss patients 
suffering from alveolar echinococcosis. 
Patients and Methods 
Patients 
All 18 patients investigated were under long-term 
medical supervision by the ‘Swiss Echinococcosis 
Studv Groun’. The diagnosis of alveolar echinococ- 
cosis-had been confirmed clinically, histologically and 
serologically (WOODTLI et al., 1985; AMMANN et al ., 
1989). All patients had received surgical treatment 
with subsequent long-term mebendazole chemother- 
apy (for details see AMMANN et al., 1989). The 
following groups of patients with confirmed alveolar 
echinococcosis of the liver were included in the study. 
Group (a). Eleven persons with comnlete surgical 
resection of the parasite lesion. No recurrences-had 
been observed UD to the end of October 1988 (cut-off 
point). The average follow-up period after surgery 
was 7 years (range 2-11 years). More detailed 
information on the patients is given in Table 1. 
Group (b). Seven persons with complete surgical 
resection of the visible parasite liver lesions reported 
by the surgeons. The 7 patients developed recurr- 
ences at time intervals of 3 years and 5 months to 11 
years and 2 months (average 6vears) after operation in 
spite of continuous~chen-&herapy: The average fol- 
low-up period was 13 years (range 10-21 years). More 
detailed information on these patients is given in 
Table 2. 
Serological assays 
Parasite-specific serum IgG was detected by EL- 
ISA. All serum samples had been kept frozen (- SO’C) 
and were examined at the same time and under 
uniform conditions in order to avoid intertrial varia- 
tions. Between 3 and 14 serum samples, during the 
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T;ksl. Information on the patients of group (a), showing no recurrence after complete surgical resection of the parasite 
Patient’s 
identitication 
Aff (1920) 
Bar (1956) 
Hub (1917) 
Mat (1947j 
Mos (1932) 
Reu (1926) 
Sb (1912) 
Sa (1949) 
SW (1936) 
Sz (1925) 
Cd (1942) 
Age at 
diagnosis 
(VCXS) ._ 
:: 
67 
Organs involved 
Sex Primary disease Recurrence 
: 
liver no 
liver no 
m liver no 
: 
liver no 
liver no 
m liver no 
: 
liver no 
liver no 
: 
liver no 
liver no 
m liver no 
Duration of chemotherapy 
(months) 
29 
24 
:z 
:; 
:: 
56 
? 
9 
Table 2. Information on the patients of group (b), showing recurrence after surgical resection of the parasite lesions 
Patient’s 
identification 
Age at 
diagnosis 
(years) Sex 
Organis involved Duration of chemotherapy 
Primary disease Recurrence (months) 
Eb (1918) 
Rm (1921) 
57 
55 
:; 
m 
f 
m 
f 
liver 
liver 
liver 
liver 
liver, kidney, 
retroperitoneal, lungs 
liver 
liver 
liver 
coeliac olexus 
77 
1:; 
117 
Ah (1930) 
Pfr (1939) 
Rei (1945) 
45 
:: 
: 
f 
liver 
liver 
liver 
liver r 
liver 
liver 
% 
112 
Table 3a. Follow-up by Em2-ELBA of patients of group (a), showing no recurrence after complete surgical resection. The 
last result for each patient corresponds to the serum sample at the cut-off point 
Patient’s 
identification 
AU at 
SwerYa 1 2 3 8 9 10 
Bar 
:: 2: x 
0 0 0 0 0 
Hub 
Mat 37 0 0 0 
Mos 
Reu 
Sb 
6i 8 x 18 8 8 rib x 0 ndb 0 
10 0 0 0 
E 70 30 x ndb 0 0 : : 0 0 0 0 
& 220 8 i : 0 
‘AU=antibody units, as percentage of a positive reference serum (see Patients and Methods); O=no antibodies 
detectable (negative). 
bnd=Not done (no serum available). 
periods indicated in Tables 3 a, b and 4 a, b, were 100% reference antibody reactivity and simultaneous- 
examined per patient. The ELISA was performed as ly to the absorbance at 404 run measured for this 
described previously (GOTTSTEIN et al., 1984; GOTT- 
STEIN, 1985), using the criteria for interpretation of 
serum.) Patients were regarded as sero-negative when 
antibodies could not be detected (AU=O). Two 
seropositivity reported by GOTTSTEIN et al. (1984). 
The results are expressed in arbitrarily defined 
antigens were included in this study: a purified 
species-specifk antigen (Em2) derived from E. multi- 
antibody units (AU), as a percentage of the antibody 
activity of a positive reference serum. (The reference 
bcularis and a crude E. granulosus antigen (EgHF) 
from hydatid cyst fluid of bovine origin (GOTTSTEIN 
serum was arbitrarily set at 100 AU, corresponding to et al., 1983, 1984). 
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Results 
The results of serological follow-up of the patients 
from groups (a) and (b) are shown in Tables 3 and 4. 
Group (a) (radical resection, tw recuwence) 
Em2-ELBA. Initially (before surgery), 9 of 11 
patients had detectable anti-Err&antibodies. One 
year after surgery, 6 of these 9 patients had already 
converted to negative (anti-En@. Of the remaining 
patients, 2 were negative (anti-Em2) 2 years after 
surgery and one 4 years after surgery. After conver- 
sion to negative, none of the patients showed any 
further anti-Em2-antibody activity up to the cut-off 
point (Table 3a). 
Table 3b. Follow-up by EgHF-ELBA of patients of group (a), showing no recurrence after complete surgical resection. 
The last result for each patient corresponds to the serum sample at the cut-off point 
Patient’s AU at Years after surgery 
identification surge# 12 3 4 5 6 7 8 9 10 
Aff 
Bar 
Hub 
Mat 
Mos 
Reu 
ii 
i,w 
Cd 
:58 23 
:i: 
14 7 24 0 19 3 17 3 18 5 20 20 
73 
0 0 
:? 428 56 i 3: 4: nodb 2: 10 nd’ 6 
3 11 0 
12 ndb 19 20 16 9 4 4 0 
63 54 30 17 17 
17 8 14 
:: 4 
“AU=antibody units, as percentage of a positive reference serum (see Patients and Methods); O=no antibodies 
detectable (negative). 
bnd=Not done (no serum available). 
Table 4a. Follow-up Em2-ELBA of patients of group (b), showing recurrence after surgical resection. The last result for 
each patient correponds to the serum sample at the cut-off point of the present study. The year 0 corresponds to the date of 
diagnosis of recurrence 
Patient’s AU at times (in after 
identification -7 -6 -5 -4 theJ11owing -2 -1 i;“‘” Pfor; and3 4 recyrrence) 6 7 8 9 10 
2 18b nd’ I$‘ nd’ nd’ nd’ nd’ nd’ 6 14 nd’ 37 22 17 3 16 0 16 0 12 0 10 27 0
VW 5b 0 4 0 0 0 0 0 0 0 0 
Ak Sb 
i 
Alt 
1: 1: 
Pfr 
Rei 
Gd 4:: 1: :!I 
0 0 0 
1 11 0 
:i 4; 3: ii : 0 0 0 
5 0 
“AU=antibody units, as a percentage of a positive reference serum (see Patients and Methods); O=no antibodies detectable 
(negative). 
bInitial values at the date of surgery. 
‘nd=Not done (no serum available). 
dNo serum available of the date at surgery. 
Table 4b. Follow-up by E&IF-ELBA of patients of group (b), showing recurrence alter surgical resection. The last result 
for each patient corresponds to the serum sample at the cut-off point of the present study. The year 0 corresponds to tbe 
date of diagnosis of recurrence 
Patient’s 
identification 
2 
VW 
Ak 
AU at 
the_3following -2 
time (in 
rrs lbefo2re 
and after 
-7 
recurrence) 
-6 -5 -4 -1 3 4 5 6 7 8 9 10 
96” ndb 123” ndb ndb ndb ndb ndb 63 nd* 79 d 
;t 
92 85 100 9 40 85 52 59 69 2 66 75 74 51 
67’ 36 21 19 21 4 0 3 0 0 0 
14s 9 4 7 0 0 2 47 
Ah 48’ 38 2s 17 20 ii 
Pfr 47’ 37 55 46 44 25 24 28 31 31 20 
Rei 45’ 63 70 61 55 28 36 24 18 10 
“AU=antibody units, as percentage of a positive reference serum (see Patients and Methods); O=no antibodies detectable 
(negative). 
‘Initial values at the date of surgery. 
bnd=Not done (no serum available). 
‘No serum available of the date at surgery. 
EgHF-ELISA. Anti-EgHF-antibodies were initial- 
ly detected in all of 11 patients. One year after 
surgery, only one patient had converted to negative. 
At the cut-off point, 7 patients still had anti-EgHF- 
antibodies detectable, while the 3 other patients had 
converted to negative (Table 3b). 
Group (b) (radical resection, but with subsequent recurr- 
ence) 
Em2-ELISA. Of 7 patients investigated, all demon- 
strated anti-En&antibody activity initially (before 
surgery). Two of them converted to negative within 2 
years after surgery. One of the latter remained 
negative despite a recurrence, the other had a rise in 
anti-Em2-antibody concentration during recurrence. 
Overall, at the time of recurrence, 6 of 7 patients were 
En&positive and most of them maintained an&Em2- 
antibody activity for a period of years following 
recurrence. At the end of the follow-up period, 2 of 7 
patients were still En&positive (Table 4a). 
EgHF-ELISA. All 7 patients were initially positive 
by EgHF-ELISA, as well as at the time of recurrence. 
At the end of the follow-up period, 6 of 7 patients 
showed anti-EgHF-antibody activity (Table 4b). 
Discussion 
The present study extends previous preliminary 
observations (LANIER et al., 1987) indicating that 
En&ELISA might prove useful for monitoring pa- 
tients with alveolar echinococcosis following surgical 
treatment. Our results indicate that 9 patients with 
anti-Em2 antibodies at the time of surgery converted 
to negative within 1 to 4 years after operation. In most 
of the oatients (7 of 9) antibodv levels had decreased 
to zero’ within the first year after operation, indepen- 
dent of the initial antibody concentration at the time 
of surgery. On the other hand, 6 of 7 patients with an 
assumed radical resection, but with recurrence de- 
monstrable on the average 6 years after surgery, 
showed anti-Em2-antibody activity at the time of 
recurrence. Although the number of patients selected 
for this study was relatively small, the present results, 
combined with those of LANIER et al. (1987), tend to 
indicate that after successful radical operation a 
significant decrease of anti-Em2 antibody concentra- 
tion may be expected, provided that no recurrence 
occurs. On the other hand, a persistence of anti-Em2 
antibody concentration may indicate the persistence 
of parasite material and in this way indirectly also 
indicate the possibility of recurrence. The use of 
common serological tests employing crude antigens 
such as E. granulosus hydatid fluid (EgHF) does not 
permit such a discrimination, as most sera from both 
groups of patients remained positive for a long period 
after surgery. Nevertheless, a tendency of the anti- 
EgHF-antibody concentration to decrease was 
observed in the group of patients with successful 
resection, confirming similar observations published 
earlier (GOTTSTEIN et al., 1984). Several points must 
be considered concerning the results presented above. 
One concerns the observation that the presence of 
anti-En&antibodies correlates only with the presence 
of parasite material and not with its viability. This was 
shown by BAUSCH et al. (1987) who, conducting a 
sero-enidemioloaical survev bv Em2-ELISA. were 
able to detect 5 km2-positive patients, with lesions in 
which the larval E. multilocularis had died spon- 
taneouslv at an early stage of infection. In all of these 
cases, the surgical resection of the dead lesions was 
followed bv a ranid decrease of anti-Em2antibodv 
concentration to zero (R. L. Rausch, personal com- 
munication). In the present study, because of these 
observations, we deliberately did not include patients 
with inoperable or partially operable lesions or who 
had received palliative surgery followed by mebenda- 
zole or albendazole therapy. Measurement of humoral 
immunity has been shown, up to now, to be of limited 
applicability for assessing the course of the disease 
during chemotherapy in such groups (MILLER et al., 
1982; SCHANTZ et al., 1983; G~TTSTEIN et al., 1984; 
LANIER et al., 1987). We definitely need new im- 
munological tools which may reliably reflect he actual 
biological status of a treated, but not completely 
removed, parasite lesion. Some indications in this 
direction may have been given by measuring circulat- 
ing or immune-complexed parasite antigens (GOTT- 
STEIN, 1984; CRAIG & NELSON, 1984), but such tests 
will have to be adapted specifically to problems of 
infections with E. multilocularis. Another point of 
discussion is the observation that all 15 patients whose 
serum was tested at the time of surgery were positive 
by EgHF-ELISA, whereas only 13 of them were 
positive by Em2-ELISA, indicating lower diagnostic 
sensitivitv of the latter test. This problem may be 
overcome by purifying new highly specific antigens 
which can be emaloved in addition to the Em2- 
antigen for diagno&c purposes. To this end, we have 
recently synthesized a recombinant E. multilocularis 
antigen in Escherichiu coli (VOGEL et al., 1988), which 
proved to be useful for the purpose in question, as in 
both of the cases mentioned above antibodies were 
detected against the recombinant antigen. 
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